bordetella pertussis pertactin
SpainDrugs containing this active substance
-
This vaccine is used for booster vaccination in children aged 3 years and older, adolescents, and adults to prevent four diseases: diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis.
Form: suspension for injection, in pre-filled syringe
Active substance Dosage bordetella pertussis toxoid 8 UG bordetella pertussis filamentous hemagglutinin 8 UG bordetella pertussis pertactin 2,5 UG poliovirus type i 40 U.D. (UNIDADES ANTIGENICAS D) poliovirus type ii 8 U.D. (UNIDADES ANTIGENICAS D) poliovirus type iii 32 U.D. (UNIDADES ANTIGENICAS D) diphtheria toxoid 2,5 Lf tetanus toxoid 5 Lf Manufacturer: Glaxosmithkline S.A.
-
It is used as a booster dose to protect children against four diseases: diphtheria, tetanus, pertussis (whooping cough), and polio.
Form: suspension for injection, in pre-filled syringe
Active substance Dosage diphtheria toxoid 30 UI tetanus toxoid 40 UI bordetella pertussis toxoid 25 µg bordetella pertussis filamentous hemagglutinin 25 µg bordetella pertussis pertactin 8 µg inactivated poliovirus type 1 mahoney produced in vero cells 40 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 2 mef-1 produced in vero cells 8 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 3 saukett produced in vero cells 32 U.D. (UNIDADES ANTIGENICAS D) Manufacturer: Glaxosmithkline S.A.
-
This vaccine is used as a booster to protect against diphtheria, tetanus, and pertussis (whooping cough) in children aged four and older, adolescents, and adults who have already completed their initial vaccination schedule. In pregnant women, it helps transfer protection against pertussis to the baby during their first months of life.
Form: suspension for injection, in pre-filled syringe
Active substance Dosage diphtheria toxoid 2 UI tetanus toxoid 20 UI bordetella pertussis toxoid 2,5 µg bordetella pertussis filamentous hemagglutinin 5 µg bordetella pertussis pertactin 3 µg pertussis fimbriae agglutinogen toxoid 5 µg Manufacturer: Sanofi Winthrop Industrie
-
This vaccine helps protect children against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and serious diseases caused by Haemophilus influenzae type b.
Form: suspension for injection, in pre-filled syringe
Active substance Dosage diphtheria toxoid Mayor o igual a 20 UI tetanus toxoid Mayor o igual a 40 UI bordetella pertussis toxoid 20 µg bordetella pertussis filamentous hemagglutinin 20 µg bordetella pertussis pertactin 3 µg pertussis fimbriae agglutinogen toxoid 5 µg inactivated poliovirus type 1 mahoney produced in vero cells 29 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 2 mef-1 produced in vero cells 7 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 3 saukett produced in vero cells 26 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 10 µg conjugate haemophilus influenzae prp-neisseria meningitidis ompc 3 µg Manufacturer: Mcm Vaccine B.V.